New Quaternary Solvent Manager Enables Polymer Chemists to Perform Analyses on a Single System that Conventionally Required Multiple Instruments and Retrofitting The Waters ACQUITY™ Advanced Polymer ...

As analytical technology continues to advance, both regulatory agencies and pharmaceutical companies are keen to avail themselves of these enhancements. In the case of chromatography, evolution from ...

The company’s next-generation ultraperformance liquid chromatography platform is designed to meet the evolving laboratory requirements for chromatographic performance. Waters’ Acquity ultraperformance ...

The ACQUITY UPLC I-Class PLUS System offers industry-leading separations performance, opening up new possibilities for maximizing the resolution and sensitivity of your methods, improving the ...

In this episode of the Chromatography Life podcast, our host Neil Lander sits down with Tom Walter, a corporate fellow at Waters, to explore the fascinating journey of UPLC column evolution. Tom, a ...

Waters tells us, "The technology is adaptable and robust enough to bridge the HPLC and UPLC performance gap while continuing to support validated assays.” To learn more about this exciting development ...

Waters Corporation announced today that its ACQUITY UPLC® System is now available with online solid phase extraction (SPE) technology from Spark Holland BV (Emmen, The Netherlands). The Waters® ...

Waters Corporation's ( WAT) ACQUITY UPLC TQD system has been approved as a medical device by the Chinese Food and Drug Administration and can now be legally promoted and sold in China. This device ...

Newborn screening allows the diagnosis of congenital adrenal hyperplasia (CAH) before symptoms appear, preventing the severe and potentially life-threatening crisis associated with this disease in ...

MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) announced today that its ACQUITY™ Advanced Polymer Chromatography™ (APC™) System is the first fully solvent-compatible UltraPerformance ...